These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 34091660)
1. Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study. Schoepf IC; Thorball CW; Ledergerber B; Engel T; Raffenberg M; Kootstra NA; Reiss P; Hasse B; Marzolini C; Thurnheer C; Seneghini M; Bernasconi E; Cavassini M; Buvelot H; Kouyos R; Günthard HF; Fellay J; Tarr PE; Clin Infect Dis; 2021 Nov; 73(9):1597-1604. PubMed ID: 34091660 [TBL] [Abstract][Full Text] [Related]
2. Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study. Schoepf IC; Thorball CW; Kovari H; Ledergerber B; Buechel RR; Calmy A; Weber R; Kaufmann PA; Nkoulou R; Schwenke JM; Braun DL; Fellay J; Tarr PE; Clin Infect Dis; 2023 Jan; 76(1):48-56. PubMed ID: 36097729 [TBL] [Abstract][Full Text] [Related]
3. Telomere Length, Traditional Risk Factors, Factors Related to Human Immunodeficiency Virus (HIV) and Coronary Artery Disease Events in Swiss Persons Living With HIV. Engel T; Raffenberg M; Schoepf IC; Kootstra NA; Reiss P; Thorball CW; Hasse B; Hirzel C; Wissel K; Roth JA; Bernasconi E; Darling KEA; Calmy A; Fellay J; Kouyos RD; Günthard HF; Ledergerber B; Tarr PE; Clin Infect Dis; 2021 Oct; 73(7):e2070-e2076. PubMed ID: 32725240 [TBL] [Abstract][Full Text] [Related]
4. Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Rotger M; Glass TR; Junier T; Lundgren J; Neaton JD; Poloni ES; van 't Wout AB; Lubomirov R; Colombo S; Martinez R; Rauch A; Günthard HF; Neuhaus J; Wentworth D; van Manen D; Gras LA; Schuitemaker H; Albini L; Torti C; Jacobson LP; Li X; Kingsley LA; Carli F; Guaraldi G; Ford ES; Sereti I; Hadigan C; Martinez E; Arnedo M; Egaña-Gorroño L; Gatell JM; Law M; Bendall C; Petoumenos K; Rockstroh J; Wasmuth JC; Kabamba K; Delforge M; De Wit S; Berger F; Mauss S; de Paz Sierra M; Losso M; Belloso WH; Leyes M; Campins A; Mondi A; De Luca A; Bernardino I; Barriuso-Iglesias M; Torrecilla-Rodriguez A; Gonzalez-Garcia J; Arribas JR; Fanti I; Gel S; Puig J; Negredo E; Gutierrez M; Domingo P; Fischer J; Fätkenheuer G; Alonso-Villaverde C; Macken A; Woo J; McGinty T; Mallon P; Mangili A; Skinner S; Wanke CA; Reiss P; Weber R; Bucher HC; Fellay J; Telenti A; Tarr PE; ; ; Clin Infect Dis; 2013 Jul; 57(1):112-21. PubMed ID: 23532479 [TBL] [Abstract][Full Text] [Related]
5. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study. Schwenke JM; Thorball CW; Schoepf IC; Ryom L; Hasse B; Lamy O; Calmy A; Wandeler G; Marzolini C; Kahlert CR; Bernasconi E; Kouyos RD; Günthard HF; Ledergerber B; Fellay J; Burkhalter F; Tarr PE; J Infect Dis; 2023 Sep; 228(6):742-750. PubMed ID: 37225667 [TBL] [Abstract][Full Text] [Related]
6. Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study. Avery EF; Kleynhans JN; Ledergerber B; Schoepf IC; Thorball CW; Kootstra NA; Reiss P; Ryom L; Braun DL; Thurnheer MC; Marzolini C; Seneghini M; Bernasconi E; Cavassini M; Buvelot H; Kouyos RD; Fellay J; Günthard HF; Tarr PE; Clin Infect Dis; 2023 Jun; 76(11):1969-1979. PubMed ID: 36688465 [TBL] [Abstract][Full Text] [Related]
7. Polygenic Hyperlipidemias and Coronary Artery Disease Risk. Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S; Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731 [TBL] [Abstract][Full Text] [Related]
8. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study. Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J Elife; 2023 Mar; 12():. PubMed ID: 36971353 [TBL] [Abstract][Full Text] [Related]
9. Minimal improvement in coronary artery disease risk prediction in Chinese population using polygenic risk scores: evidence from the China Kadoorie Biobank. Yang S; Sun D; Sun Z; Yu C; Guo Y; Si J; Sun D; Pang Y; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Pang Z; Schmidt D; Stevens R; Clarke R; Chen J; Chen Z; Lv J; Li L; Chin Med J (Engl); 2023 Oct; 136(20):2476-2483. PubMed ID: 37200020 [TBL] [Abstract][Full Text] [Related]
10. Polygenic Risk Scores in Predicting Coronary Artery Disease in Symptomatic Patients. A Validation Study. Kujala I; Vangipurapu J; Maaniitty T; Saraste A; Kere J; Knuuti J J Atheroscler Thromb; 2024 Jul; 31(7):1058-1071. PubMed ID: 38403640 [TBL] [Abstract][Full Text] [Related]
11. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data. Agbaedeng TA; Noubiap JJ; Mofo Mato EP; Chew DP; Figtree GA; Said MA; van der Harst P Atherosclerosis; 2021 Sep; 333():48-55. PubMed ID: 34425527 [TBL] [Abstract][Full Text] [Related]
12. Polygenic Risk Score Associates With Atherosclerotic Plaque Characteristics at Autopsy. Cornelissen A; Gadhoke NV; Ryan K; Hodonsky CJ; Mitchell R; Bihlmeyer NA; Duong T; Chen Z; Dikongue A; Sakamoto A; Sato Y; Kawakami R; Mori M; Kawai K; Fernandez R; Ghosh SKB; Braumann R; Abebe B; Kutys R; Kutyna M; Romero ME; Kolodgie FD; Miller CL; Hong CC; Grove ML; Brody JA; Sotoodehnia N; Arking DE; Schunkert H; Mitchell BD; Guo L; Virmani R; Finn AV Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):300-313. PubMed ID: 37916415 [TBL] [Abstract][Full Text] [Related]
13. Influence of blood pressure polygenic risk scores and environmental factors on coronary artery disease in the Korean Genome and Epidemiology Study. Woo K; Lim JE; Lee EY J Hum Hypertens; 2024 Mar; 38(3):221-227. PubMed ID: 37985823 [TBL] [Abstract][Full Text] [Related]
14. Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial. Zou RS; Ruan Y; Truong B; Bhattacharya R; Lu MT; Karády J; Bernardo R; Finneran P; Hornsby W; Fitch KV; Ribaudo HJ; Zanni MV; Douglas PS; Grinspoon SK; Patel AP; Natarajan P J Am Heart Assoc; 2024 Apr; 13(7):e033413. PubMed ID: 38533953 [TBL] [Abstract][Full Text] [Related]
15. Contribution of Lipoprotein(a) to Polygenic Risk Prediction of Coronary Artery Disease: A Prospective UK Biobank Analysis. Manikpurage HD; Paulin A; Girard A; Eslami A; Mathieu P; Thériault S; Arsenault BJ Circ Genom Precis Med; 2023 Oct; 16(5):470-477. PubMed ID: 37753708 [TBL] [Abstract][Full Text] [Related]
17. Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores. Dietrich LG; Thorball CW; Ryom L; Burkhalter F; Hasse B; Thurnheer MC; Weisser M; Schmid P; Bernasconi E; Darling KEA; Buvelot H; Fellay J; Ledergerber B; Tarr PE; J Infect Dis; 2021 Jun; 223(12):2145-2153. PubMed ID: 33151293 [TBL] [Abstract][Full Text] [Related]
18. Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study. Mujwara D; Henno G; Vernon ST; Peng S; Di Domenico P; Schroeder B; Busby GB; Figtree GA; Bottà G J Am Heart Assoc; 2022 Jun; 11(12):e025236. PubMed ID: 35699184 [TBL] [Abstract][Full Text] [Related]